Overview

Fluvastatin in the Therapy of Acute Coronary Syndrome

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Collaborator:
Ministry of Health, Czech Republic
Treatments:
Fluvastatin